Relative and Absolute Bioavailability Study of Emicizumab to Bridge Drug Products and Subcutaneous Injection Sites in Healthy Volunteers
Author:
Affiliation:
1. Chugai Pharmaceutical Co, Ltd Tokyo Japan
2. Chugai Pharma Manufacturing Co, Ltd Tokyo Japan
3. CPC Clinic Medipolis Medical Research Institute Kagoshima Japan
4. Clinical Research Hospital Tokyo Tokyo Japan
Publisher
Wiley
Subject
Pharmacology (medical),Pharmaceutical Science
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpdd.617
Reference34 articles.
1. The Hemophilias — From Royal Genes to Gene Therapy
2. The use of enhanced half-life coagulation factor concentrates in routine clinical practice: guidance from UKHCDO
3. Implications of coagulation factor VIII and IX pharmacokinetics in the prophylactic treatment of haemophilia
4. Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia
5. Guidelines for the management of hemophilia
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Emicizumab as a Promising Form of Therapy for Type A Hemophilia - AReview of Current Knowledge from Clinical Trials;Current Protein & Peptide Science;2024-11
2. Efficacy and Safety of Adeno-Associated Virus-Based Clinical Gene Therapy for Hemophilia: A Systematic Review and Meta-Analysis;Human Gene Therapy;2024-02-01
3. Pharmacokinetics and coagulation biomarkers in children and adults with hemophilia A receiving emicizumab prophylaxis every 1, 2, or 4 weeks;Research and Practice in Thrombosis and Haemostasis;2024-01
4. Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b, open-label trial;Blood Journal;2023-12-21
5. Low-dose emicizumab prophylaxis in patients with severe hemophilia A: a retrospective study bringing new hope for our patients;Journal of Thrombosis and Haemostasis;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3